Company / Gross Profit
BioNexus Gene Lab Corp Gross Profit History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.1M
FY2025
5-year range
$1.1M / $2.3M
FY2021-FY2025
Trend
-15.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 7 years, ranging from $55,888 in FY2019 to $2M in FY2021.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -8.8%.
Declined from $1M to $1M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- -8.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.8%, indicating a declining trend.
- In FY2025, gross profit decreased 15.8% year-over-year.
- Peak gross profit was recorded in FY2021.
- Lowest gross profit in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | -15.8% |
| FY2024 | $1.3M | -3.0% |
| FY2023 | $1.3M | +5.6% |
| FY2022 | $1.3M | -44.5% |
| FY2021 | $2.3M | +31.8% |
| FY2020 | $1.7M | +2977.3% |
| FY2019 | $55.9K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026